File(s) not publicly available
Is Peripheral BDNF Promoter Methylation a Preclinical Biomarker of Dementia?
Version 2 2024-06-06, 01:53
Version 1 2022-04-01, 08:28
journal contribution
posted on 2024-06-06, 01:53 authored by Peter FransquetPeter Fransquet, K Ritchie, V Januar, R Saffery, ML Ancelin, J RyanIs Peripheral BDNF Promoter Methylation a Preclinical Biomarker of Dementia?
History
Journal
Journal of Alzheimer's DiseaseVolume
73Pagination
645-655Location
Amsterdam, The NetherlandsPublisher DOI
ISSN
1387-2877eISSN
1875-8908Language
EnglishPublication classification
C1 Refereed article in a scholarly journalIssue
2Publisher
IOS PressUsage metrics
Keywords
ALZHEIMERS-DISEASE RISKBDNFbiomarkersbloodBLOODCONVERSIONdementiaDISCOVERYDNA methylationDNA METHYLATIONepigeneticsLife Sciences & BiomedicineMILD COGNITIVE IMPAIRMENTNeurosciencesNeurosciences & NeurologyPATHOGENESISPOTENTIAL BIOMARKERScience & TechnologySTATE3202 Clinical sciences3209 Neurosciences
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC